195 related articles for article (PubMed ID: 32366477)
1. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
[TBL] [Abstract][Full Text] [Related]
2. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract][Full Text] [Related]
3. HACE1 is a potential tumor suppressor in osteosarcoma.
El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
[TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
[TBL] [Abstract][Full Text] [Related]
5. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
[TBL] [Abstract][Full Text] [Related]
6. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitylation of active Rac1 by the E3 ubiquitin-ligase HACE1.
Mettouchi A; Lemichez E
Small GTPases; 2012; 3(2):102-6. PubMed ID: 22790197
[TBL] [Abstract][Full Text] [Related]
8. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
Goka ET; Lippman ME
Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
[TBL] [Abstract][Full Text] [Related]
9. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
[TBL] [Abstract][Full Text] [Related]
10. RNA-Binding RING E3-Ligase DZIP3/hRUL138 Stabilizes Cyclin D1 to Drive Cell-Cycle and Cancer Progression.
Kolapalli SP; Sahu R; Chauhan NR; Jena KK; Mehto S; Das SK; Jain A; Rout M; Dash R; Swain RK; Lee DY; Rusten TE; Chauhan S; Chauhan S
Cancer Res; 2021 Jan; 81(2):315-331. PubMed ID: 33067265
[TBL] [Abstract][Full Text] [Related]
11. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
[TBL] [Abstract][Full Text] [Related]
12. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
[TBL] [Abstract][Full Text] [Related]
13. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.
El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R
Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression.
Liu Z; Chen P; Gao H; Gu Y; Yang J; Peng H; Xu X; Wang H; Yang M; Liu X; Fan L; Chen S; Zhou J; Sun Y; Ruan K; Cheng S; Komatsu M; White E; Li L; Ji H; Finley D; Hu R
Cancer Cell; 2014 Jul; 26(1):106-20. PubMed ID: 25026213
[TBL] [Abstract][Full Text] [Related]
15. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
Nat Commun; 2013; 4():2180. PubMed ID: 23864022
[TBL] [Abstract][Full Text] [Related]
16. Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
Kim I; Shin SH; Lee JE; Park JW
Oncogene; 2019 May; 38(19):3651-3666. PubMed ID: 30659265
[TBL] [Abstract][Full Text] [Related]
17. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.
Li K; Zheng X; Tang H; Zang YS; Zeng C; Liu X; Shen Y; Pang Y; Wang S; Xie F; Lu X; Luo Y; Li Z; Bi W; Jia X; Huang T; Wei R; Huang K; Chen Z; Zhu Q; He Y; Zhang M; Gu Z; Xiao Y; Zhang X; Fletcher JA; Wang Y
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34143182
[TBL] [Abstract][Full Text] [Related]
18. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH
Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589
[TBL] [Abstract][Full Text] [Related]
19. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.
Tortola L; Nitsch R; Bertrand MJM; Kogler M; Redouane Y; Kozieradzki I; Uribesalgo I; Fennell LM; Daugaard M; Klug H; Wirnsberger G; Wimmer R; Perlot T; Sarao R; Rao S; Hanada T; Takahashi N; Kernbauer E; Demiröz D; Lang M; Superti-Furga G; Decker T; Pichler A; Ikeda F; Kroemer G; Vandenabeele P; Sorensen PH; Penninger JM
Cell Rep; 2016 May; 15(7):1481-1492. PubMed ID: 27160902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
